Blood-Brain Barrier In Vitro Models and Their Application in Toxicology: The Report and Recommendations of ECVAM Workshop 49

Alternatives to Laboratory Animals

Volumn 32, Issue 1, 2004, Pages 37-50

  Prieto, Pilar ^a   Blaauboer, Bas J ^b   De Boer, Albertus Gerrit ^c   Boveri, Monica ^a   Cecchelli, Romeo ^d   Clemedson, Cecilia ^e   Coecke, Sandra ^a   Forsby, Anna ^f   Galla, Hans Joachim ^g   Garberg, Per ^h   Greenwood, John ⁱ   Price, Anna ^a   Tähti, Hanna ^j  

^a JOINT RESEARCH CENTRE   (Italy)

^b UTRECHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d UNIVERSITÉ D'ARTOIS   (France)

^e Expertrådet ECB   (Sweden)

^f STOCKHOLM UNIVERSITY   (Sweden)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h BIOVITRUM AB   (Sweden)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

11BETA,17BETA DIHYDROXY 6 METHYL 17ALPHA (1 PROPYNYL)ANDROSTA 1,4,6 TRIEN 3 ONE; CAFFEINE; CIMETIDINE; CYCLOSPORIN; DEXAMETHASONE; DIAZEPAM; DIGOXIN; GLYCEROL; INULIN; LACTIC ACID; LEVODOPA; MORPHINE; NICOTINE; PHENAZONE; PHENYTOIN; VERAPAMIL; VINBLASTINE; VINCRISTINE; WARFARIN; ZIDOVUDINE;

BLOOD BRAIN BARRIER; CELL CULTURE; CELL IMMORTALIZATION; CELL LINE; CELL TRANSFORMATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHEMICAL ANALYSIS; COCULTURE; CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; KINETICS; MEASUREMENT; MODEL; NEUROTOXICITY; NONHUMAN; ORGANIZATION; PARTITION COEFFICIENT; PRIORITY JOURNAL; SCIENCE; TARGET ORGAN; TECHNIQUE; TOXICITY; TRANSPORT KINETICS;

EID: 11144356229     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403200107     Document Type: Conference Paper

References (77)

1. Anon. (1994). ECVAM News & Views. ATLA 22, 7-11.
2. Anon. (2001). White Paper on a Strategy for a Future Chemicals Policy (COM(2001)88 final), 32pp. Brussels, Belgium: European Commission. Website http://europa.eu.int/comm/enterprise/chemicals/chempol/whitepaper/reach.htm (Accessed 18.11.03).
3. Anon. (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products (Text with EEA relevance). Official Journal of the European Union L66, 26-35.
4. Kusuhara, H. & Sugiyama, Y. (2001). Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (part 1). Drug Discovery Today 6, 150-156.
5. Feng, M.R. (2002). Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo. Current Drug Metabolism 3, 647-657.
6. Nitz, T., Eisenblätter, T., Haselbach, M. & Galla, H-J. (2001). Recent advances in the development of cell culture models for the blood-brain- and blood-CSF-barrier. In Blood-Brain Barrier Delivery and Brain Pathology (ed. J.L. Kluwer), pp. 45-62. New York, NJ, USA: Plenum Press.
7. Haselbach, M., Wegener, J., Decker, S., Engelbertz, C. & Galla, H-J. (2001). Porcine choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes. Microscopy Research and Technique 52, 137-152.
8. Strazielle, N. & Ghersi-Egea, J-F. (1999). Demonstration of a couplet metabolism-efflux process at the choroid plexus as a mechanism of brain protection towards xenobiotics. Journal of Neuroscience 19, 6275-6289.
9. Savettieri, G., Di Liegro, I., Catania, C., Licata, L., Pitarresi, G.L., D'Agostino, S., Schiera, G., De Caro, V., Giandalia, G., Giannola, L.I. & Cestelli, A. (2000). Neurons and ECM regulate occluding localization in brain endothelial cells. Molecular Neuroreceptors 11, 1081-1084.
10. Bauer, H.C. & Bauer, H. (2000). Neural induction of the blood-brain barrier: still an enigma. Cell and Molecular Neurobiology 20, 13-28.
11. de Vries, H.E., Kuiper, J., de Boer, A.G., van Berkel, J.C. & Breimer, D.D. (1997). The blood-brain barrier in neuroinflammatory diseases. Pharmacological Reviews 49, 143-155.
12. Grant, G.A., Abbott, N.J. & Janigro, D. (1998). Understanding the physiology of the blood-brain barrier: in vitro models. News in Physiological Sciences 13, 287-293.
13. Andersen, M.E. (1991). Physiological modelling of organic compounds. Annals of Occupational Hygiene 35, 309-321.
14. Poulin, P. & Krishnan, K. (1996). A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals. Toxicology and Applied Pharmacology 136, 126-130.
15. DeJongh, J., Verhaar, H.J. & Hermens, J.L. (1998). Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs). Toxicological Sciences 45, 26-32.
16. Meulenberg, C.J. & Vijverberg, H.P. (2000). Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds. Toxicology and Applied Pharmacology 165, 206-216.
17. Worth, A.P. & Balls, M., eds (2002). Alternative (Non-animal) Methods for Chemicals Testing: Current Status and Future Prospects. A report prepared by ECVAM and the ECVAM working group on chemicals. ATLA 30, Suppl. 1, 1-125.
18. Forsby, A., Pilli, F., Bianchi, V. & Walum, E. (1995). Determination of critical cellular neurotoxic concentrations in human neuroblastoma (SH-SY5Y) cell cultures. ATLA 23, 800-811.
19. DeJongh, J., Forsby, A., Houston, J.B., Beckman, M., Combes, R. & Blaauboer, B.J. (1999). An integrated approach to the prediction of systemic toxicity using computer-based biokinetic models and biological in vitro test methods: overview of a prevalidation study based on the ECITTS project. Toxicology in Vitro 13, 549-554.
20. Rubin, L.L. & Staddon, J.M. (1999). The cell biology of the blood-brain barrier. Annual Review of Neuroscience 22, 11-23.
21. Garberg, P. (1998). In vitro models of the bloodbrain barrier. ATLA 26, 821-847.
22. de Boer, A.G. & Gaillard, P.J. (2002). In vitro models of the blood-brain barrier: when to use which? Current Medicinal Chemistry - Central Nervous System Agents 2, 203-209.
23. Méresse, S., Dehouck, M.P., Delorme, P., Bensaid, M., Tauber, J.P., Delbart, C., Fruchart, J.C. & Cecchelli, R. (1989). Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. Journal of Neurochemistry 53, 1363-1371.
24. Dehouck, M.P., Méresse, S., Delorme, P., Fruchart, J-C. & Cecchelli, R. (1990). An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. Journal of Neurochemistry 54, 1798-1801.
25. Dehouck, M.P., Dehouck, B., Schluep, C., Fruchart, J.C., Lemaire, M. & Cecchelli, R. (1995). Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier. European Journal of Pharmaceutical Sciences 3, 357-365.
26. Fenart, L., Buée-Scherrer, V., Descamps, L., Duhem, C., Poullain, M.G., Cecchelli, R. & Dehouck, M.P. (1998). Inhibition of P-glycoprotein at the bloodbrain barrier level: in vitro studies of its implication in blood-brain barrier integrity and in drug transport to the brain by an in vitro model of the blood-brain barrier. Pharmaceutical Research 15, 993-1000.
27. Dehouck, M.P., Vigne, P., Torpier, G., Breittmayer, J.P., Cecchelli, R. & Frelin, C. (1997). Endothelin-I as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries. Journal of Cerebral Blood Flow and Metabolism 17, 464-469.
28. Descamps, L., Dehouck, M.P., Torpier, G. & Cecchelli, R. (1996). Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. American Journal of Physiology - Heart and Circulatory Physiology 270, 1149-1158.
29. Fillebeen, C., Descamps, L., Dehouck, M.P., Fenart, L., Benaissa, M., Spick, G., Cecchelli, R. & Pierce, A. (1999). Receptor mediated transcytosis of lactoferrin through the blood-brain barrier. Journal of Biological Chemistry 274, 7011-7017.
30. Cecchelli, R., Dehouck, B., Descamps, L., Fenart, L., Buée-Scherrer, V., Duhem, C., Lundquist, S., Rentfel, M., Torpier, G. & Dehouck, M.P. (1999). In vitro model for evaluating drug transport across the blood-brain barrier. Advanced Drug Delivery Reviews 36, 165-178.
31. Lundquist, S., Renftel, M., Brillault, J., Fenart, L., Cecchelli, R. & Dehouck, M.P. (2002). Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharmaceutical Research 7, 976-981.
32. Hoheisel, D., Nitz, T., Franke, H., Wegener, J., Hakvoort, A., Tilling, T. & Galla, H-J. (1998). Hydrocortisone reinforces the blood-brain barrier properties in a serum-free cell culture system. Biochemical and Biophysical Research Communications 244, 231-316.
33. Lohmann, C., Hüwel, S. & Galla, H-J. (2002). Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. Journal of Drug Targeting 10, 263-276.
34. Eisenblätter, T., Hüwel, S. & Galla, H-J. (2003). Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Brain Research 971, 221-231.
35. Nitz, T., Eisenblätter, T., Psathaki, K. & Galla, H-J. (2003). Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro. Brain Research 981, 30-40.
36. Gaillard, P.J., van der Meide, P.H., de Boer, A.G. & Breimer, D.D. (2001). Glucocorticoid and type I interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis. NeuroReport 12, 2189-2193.
37. Uyttendaele, H., Closson, V., Wu, G., Roux, F., Weinmaster, G. & Kitajewski, J. (2000). Notch4 and Jagged-1 induce microvessel differentiation of rat brain endothelial cells. Microvascular Research 60, 91-103.
38. Drexler, H.G., Quentmeier, H., Dirks, W.G. & MacLeod, R.A. (2002). Bladder carcinoma cell line ECV304 is not a model system for endothelial cells. In Vitro Cellular and Developmental Biology - Animal 38, 185-186.
39. Dirks, W.G., MacLeod, R.A. & Drexler, H.G. (1999). ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cellular and Developmental Biology - Animal 35, 558-559.
40. Lundquist, S., Renftel, M., Brillault, J., Fenart, L., Cecchelli, R. & Dehouck, M.P. (2002). Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharmaceutical Research 19, 976-981.
41. Gaillard, P.J., Voorwinden, L.H., Nielsen, J.L., Ivanov, A., Atsumi, R., Engman, H., Ringbom, C., de Boer, A.G. & Breimer, D.D. (2001). Establishment and functional characterizarion of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. European Journal of Pharmacuetical Sciences 12, 215-222.
42. Kramer, S.D., Schutz, Y.B., Wunderli-Allenspach, H., Abbott, N.J. & Begley, D.J. (2002). Lipids in blood-brain barrier models in vitro. II. Influence of glial cells on lipid classes and lipid fatty acids. In Vitro Cellular and Developmental Biology - Animal 38, 566-571.
43. Tilling, T.H., Engelbertz, C.H., Decker, S.T., Korte, D., Hüwel, S. & Galla, H-J. (2002). Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures. Cell and Tissue Research 310, 19-29.
44. Lohmann, C., Krischke, M., Wegener, J. & Galla, H-J. (2004). Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and independent pathways. Brain Research 995, 184-196.
45. Tähti, H., Nevala, H. & Toimela, T. (2003). Refining in vitro neurotoxicity testing - the development of blood-brain barrier models. ATLA 31, 273-276.
46. Toimela, T. Mäenpää, H., Mannerström, M. & Tähti, H. (2004). Development of an in vitro blood-brain barrier model - cytotoxicity of mercury and aluminum. Toxicology and Applied Pharmacology 195, 73-82.
47. Blaauboer, B.J. (2003). Biokinetic and toxicodynamic modelling and its role in toxicological research and risk assessment. ATLA 31, 277-281.
48. DeJongh, J., Nordin-Andersson, M., Ploeger, B. & Forsby, A. (1999). Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations. Toxicology and Applied Pharmacology 158, 261-268.
49. Poulin, P. & Krishnan, K. (1996). A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals. Toxicology and Applied Pharmacology 136, 126-130.
50. DeJongh, J., Verhaar, H.J. & Hermens, J.L.M. (1997). A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Archives of Toxicology 72, 17-25.
51. Lee, G., Dallas, S., Hong, M. & Bendayan, R. (2001). Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacological Reviews 53, 569-596.
52. Sun, H., Dai, H., Shaik, N. & Elmquist, W.F. (2003). Drug efflux transporters in the CNS. Advanced Drug Delivery Reviews 55, 83-105.
53. Gaillard, P.J., de Boer, A.G. & Breimer, D.D. (2003). Pharmacological investigations on lipopolysaccharide-induced permeability changes in the bloodbrain barrier in vitro. Microvascular Research 65, 24-31.
54. Ghersi-Egea, J.F. & Strazielle, N. (2002). Choroid plexus transporters for drugs and other xenobiotics. Journal of Drug Targeting 10, 353-357.
55. Roux, F., Durieu-Trautmann, O., Chaverot, N., Claire, M., Mailly, P., Bourre, J.M., Strosberg, A.D. & Couraud, P.O. (1994). Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. Journal of Cellular Physiology 159, 101-113.
56. Greenwood, J., Pryce, G., Devine, L., Male, D.K., dos Santos, W.L., Calder, V.L. & Adamson, P. (1996). SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics. Journal of Neuroimmunology 71, 51-63.
57. Terasaki, T. & Hosoya, K. (2001). Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Biological and Pharmaceutical Bulletin 24, 111-118.
58. Blasig, I.E., Giese, H., Schroeter, M.L., Sporbert, A., Utepbergenov, D.I., Buchwalow, I.B., Neubert, K., Schonfelder, G., Freyer, D., Schimke, I., Siems, W.E., Paul, M., Haseloff, R.F. & Blasig, R. (2001). NO and oxyradical metabolism in new cell lines of rat brain capillary endothelial cells forming the blood-brain barrier. Microvascular Research 62, 114-127.
59. Lechardeur, D., Schwartz, B., Paulin, D. & Scherman, D. (1995). Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. Experimental Cell Research 220, 161-170.
60. Kido, Y., Tamai, I., Okamoto, M., Suzuki, F. & Tsuji, A. (2000). Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharmaceutical Research 17, 55-62.
61. Mooradian, D.L. & Diglio, C.A. (1991). Production of a transforming growth factor-beta-like growth factor by RSV-transformed rat cerebral microvascular endothelial cells. Tumour Biology 12, 171-183.
62. Xu, J., Qu, Z.X., Moore, S.A., Hsu, C.Y. & Hogan, E.L. (1992). Receptor-linked hydrolysis of phosphoinositides and production of prostacyclin in cerebral endothelial cells. Journal of Neurochemistry 58, 1930-1935.
63. Asaba, H., Hosoya, K., Takanaga, H., Ohtsuki, S., Tamura, E., Takizawa, T. & Terasaki, T. (2000). Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2. Journal of Neurochemistry 75, 1907-1916.
64. Wijsman, J.A. & Shivers, R.R. (1998). Immortalized mouse brain endothelial cells are ultrastructurally similar to endothelial cells and respond to astrocyte-conditioned medium. In Vitro Cellular and Developmental Biology - Animal 34, 777-784.
65. Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I. & Tsuruo, T. (1992). Functional involvement of P-glycoprotein in blood-brain barrier. Journal of Biological Chemistry 267, 20383-20391.
66. Sobue, K., Yamamoto, N., Yoneda, K., Hodgson, M.E., Yamashiro, K., Tsuruoka, N., Tsuda, T., Katsuya, H., Miura, Y., Asai, K. & Kato, T. (1999). Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neuroscience Research 35, 155-164.
67. Durieu-Trautmann, O., Foignant-Chaverot, N., Perdomo, J., Gounon, P., Strosberg, A.D. & Couraud, P.O. (1991). Immortalization of brain capillary endothelial cells with maintenance of structural characteristics of the blood-brain barrier endothelium. In Vitro Cellular and Developmental Biology - Animal 27, 771-778.
68. Stins, M.F., Prasadarao, N.V., Zhou, J., Arditi, M. & Kim, K.S. (1997). Bovine brain microvascular endothelial cells transfected with SV40-large T antigen: development of an immortalized cell line to study pathophysiology of CNS disease. In Vitro Cellular and Developmental Biology - Animal 33, 243-247.
69. Teifel, M. & Friedl, P. (1996). Establishment of the permanent microvascular endothelial cell line PBMEC/C1-2 from porcine brains. Experimental Cell Research 228, 50-57.
70. Muruganandam, A., Herx, L.M., Monette, R., Durkin, J.P. & Stanimirovic, D.B. (1997). Development of immortalized cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB Journal 11, 1187-1197.
71. Xiao, L., Yang, C., Dorovini-Zis, K., Tandon, N.N., Ades, E., Lal, A.A. & Udhayakumar, V. (1996). Plasmodium falciparum: involvement of additional receptors in the cytoadherence of infected erythrocytes to microvascular endothelial cells. Experimental Parasitology 84, 42-55.
72. Prudhomme, J.G., Sherman, I.W., Land, K.M., Moses, A.V., Stenglein, S. & Nelson, J.A. (1996). Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. International Journal of Parasitology 26, 647-655.
73. Kallmann, B.A., Wagner, S., Hummel, V., Buttmann, M., Bayas, A., Tonn, J.C. & Rieckmann, P. (2002). Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB Journal 16, 589-591.
74. Drexler, H.G., Quentmeier, H., Dirks, W.G. & MacLeod, R.A. (2002). Bladder carcinoma cell line ECV304 is not a model system for endothelial cells. In Vitro Cellular and Developmental Biology - Animal 38, 185-186.
75. Veronesi, B. (1996). Characterization of the MDCK cell line for screening neurotoxicants. Neurotoxicology 17, 433-443.
76. Smith, B.J., Doran, A.C., McLean, S., Tingley, F.D. III, O'Neill, B.T. & Kajiji, S.M. (2001). P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists. Journal of Pharmacology and Experimental Therapeutics 298, 1252-1259.
77. Batrakova, E.V., Miller, D.W., Li, S., Alakhov, V.Y., Kabanov, A.V. & Elmquist, W.F. (2001). Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. Journal of Pharmacology and Experimental Therapeutics 296, 551-557.